Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:32 AM
Ignite Modification Date:
2025-12-25 @ 4:32 AM
NCT ID:
NCT01489618
Eligibility Criteria:
Inclusion Criteria:
* Age \> 18 years and \< 65 years
* Common variable immunodeficiency according to the WHO criteria,
* Patients treated with intravenous or subcutaneous immunoglobulin.
* Written informed consent
* Absence of acute infections, or other evolutive diseases related to the (cancer, auto-immune disease…)
Exclusion Criteria:
* IgG subclass deficiency
* IgA selective deficiency,
* Other primary humoral deficiency (X-linked agammaglobulinemia, Hyper IgM syndrome),
* Long course treatment with corticosteroids \> 5mg per day
* Chemotherapy in the last 3 years,
* Prior pneumococcal vaccination in the last 2 years.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT01489618
Study Brief:
Protocol Section:
NCT01489618